Sana Biotechnology, Inc.SANANASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank43
3Y CAGR-13.1%
5Y CAGR+1.5%
Year-over-Year Change
Research and development spending
3Y CAGR
-13.1%/yr
vs +166.0%/yr prior
5Y CAGR
+1.5%/yr
Recent deceleration
Acceleration
-179.1pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $131.98M | -36.8% |
| 2024 | $208.68M | -5.1% |
| 2023 | $219.84M | +9.4% |
| 2022 | $201.00M | -34.4% |
| 2021 | $306.50M | +149.8% |
| 2020 | $122.68M | +2.8% |
| 2019 | $119.38M | +2874.0% |
| 2018 | $4.01M | - |